CA2510964A1 - Therapeutic phenoxyalkylfurans and intermediates therefor - Google Patents

Therapeutic phenoxyalkylfurans and intermediates therefor Download PDF

Info

Publication number
CA2510964A1
CA2510964A1 CA002510964A CA2510964A CA2510964A1 CA 2510964 A1 CA2510964 A1 CA 2510964A1 CA 002510964 A CA002510964 A CA 002510964A CA 2510964 A CA2510964 A CA 2510964A CA 2510964 A1 CA2510964 A1 CA 2510964A1
Authority
CA
Canada
Prior art keywords
phenoxyalkylfurans
therapeutic
intermediates therefor
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002510964A
Other languages
French (fr)
Other versions
CA2510964C (en
Inventor
David J. Aldous
Thomas R. Bailey
Guy Dominic Diana
Theodore J. Nitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/242,528 external-priority patent/US5514679A/en
Application filed by Individual filed Critical Individual
Publication of CA2510964A1 publication Critical patent/CA2510964A1/en
Application granted granted Critical
Publication of CA2510964C publication Critical patent/CA2510964C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compounds of formula (A), Z is (B) (see formula A) (see formula B) wherein: R1 and R2 are each independently hydrogen, halo, alkyl or the like; Y is alkylene of 3 to 9 carbon atoms; R3 and R4 are each independently chosen from hydrogen, alkyl, alkoxy, hydroxy, cycloalkyl, or the like; R5 is alkoxycarbonyl, alkyltetrazolyl, phenyl or a heterocycle are useful as antipicornaviral agents.
CA002510964A 1994-05-13 1995-05-11 Therapeutic phenoxyalkylfurans and intermediates therefor Expired - Lifetime CA2510964C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/242,528 1994-05-13
US08/242,528 US5514679A (en) 1994-05-13 1994-05-13 Therapeutic phenoxyalklpyridazines and intermediates therefor
CA002190129A CA2190129C (en) 1994-05-13 1995-05-11 Therapeutic phenoxyalkylpyridazines and intermediates therefor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002190129A Division CA2190129C (en) 1994-05-13 1995-05-11 Therapeutic phenoxyalkylpyridazines and intermediates therefor

Publications (2)

Publication Number Publication Date
CA2510964A1 true CA2510964A1 (en) 1995-11-23
CA2510964C CA2510964C (en) 2009-06-30

Family

ID=35276910

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002510964A Expired - Lifetime CA2510964C (en) 1994-05-13 1995-05-11 Therapeutic phenoxyalkylfurans and intermediates therefor

Country Status (1)

Country Link
CA (1) CA2510964C (en)

Also Published As

Publication number Publication date
CA2510964C (en) 2009-06-30

Similar Documents

Publication Publication Date Title
KR100257619B1 (en) Azole compounds, their production and use
FI931202A0 (en) ANTIFUNGALA CYKLISKA PEPTIDER OCH FOERFARANDE FOER FRAMSTAELLNING AV DESSA
CA2156078A1 (en) New imidazopyridines
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
AU9107491A (en) 1,4-benzothiazepine derivative
ZA927606B (en) Antifungal agent.
HK1012341A1 (en) Pyrrolocarbazole
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
EP0774257A3 (en) Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration
CA2103072A1 (en) Pleuromutilin derivatives
TWI265161B (en) Oxime compounds, their use, and intermediates for their production
CA2510964A1 (en) Therapeutic phenoxyalkylfurans and intermediates therefor
AU623500B2 (en) Carboxylimino benzothiazole derivatives
EP0717039A4 (en) Novel triazole compound, process for producing the same, and pest control agent
EP0516860A4 (en) Chromone derivative and aldose reductase inhibitor containing the same as active ingredient
CA2111096A1 (en) Thiazolidinedione Hypoglycemic Agents
GR3020420T3 (en) Alkyl derivatives of trazodone with cns activity.
CA2027542A1 (en) Uv-absorbing cyclic enaminoketones
GB9015485D0 (en) Heterocyclic derivatives
CA2036643A1 (en) Sulfur-containing esters as synergists of amine and phenolic antioxidants
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
TW239123B (en)
TW270112B (en) Novel compounds capable of lowering blood-lipid activity and its production process and its novel intermediates

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150511